Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma

Clinical responses to anticancer therapies in advanced soft tissue sarcoma (STS) are unluckily restricted to a small subgroup of patients. Much of the inter-individual variability in treatment efficacy is as result of polymorphisms in genes encoding proteins involved in drug pharmacokinetics and pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasqui, Adriano, Boddi, Anna, Campanacci, Domenico Andrea, Scoccianti, Guido, Bernini, Andrea, Grasso, Daniela, Gambale, Elisabetta, Scolari, Federico, Palchetti, Ilaria, Palomba, Annarita, Fancelli, Sara, Caliman, Enrico, Antonuzzo, Lorenzo, Pillozzi, Serena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369086/
https://www.ncbi.nlm.nih.gov/pubmed/35955506
http://dx.doi.org/10.3390/ijms23158360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369086/
https://www.ncbi.nlm.nih.gov/pubmed/35955506
http://dx.doi.org/10.3390/ijms23158360

Ejemplares similares